BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jiang SX, Mikami T, Umezawa A, Saegusa M, Kameya T, Okayasu I. Gastric large cell neuroendocrine carcinomas: a distinct clinicopathologic entity. Am J Surg Pathol. 2006;30:945-953. [PMID: 16861964 DOI: 10.1097/00000478-200608000-00003] [Cited by in Crossref: 75] [Cited by in F6Publishing: 65] [Article Influence: 4.7] [Reference Citation Analysis]
Number Citing Articles
1 Kubota T, Ohyama S, Hiki N, Nunobe S, Yamamoto N, Yamaguchi T. Endocrine carcinoma of the stomach: clinicopathological analysis of 27 surgically treated cases in a single institute. Gastric Cancer. 2012;15:323-330. [PMID: 22252152 DOI: 10.1007/s10120-011-0122-5] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.9] [Reference Citation Analysis]
2 Caruso RA, Napoli P, Nania A, Parisi A, Fedele F, Zuccalà V. Mitochondrion-rich differentiated adenocarcinomas of the stomach: clinicopathological, immunohistochemical and electron microscopy study of nine cases. Virchows Arch 2010;456:499-505. [DOI: 10.1007/s00428-010-0912-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
3 Takezawa K, Okamoto I, Fukuoka J, Tanaka K, Kaneda H, Uejima H, Yoon H, Imakita M, Fukuoka M, Nakagawa K. Large Cell Neuroendocrine Carcinoma of the Mediastinum with α-Fetoprotein Production. Journal of Thoracic Oncology 2008;3:187-9. [DOI: 10.1097/jto.0b013e3181623359] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
4 Liang P, Wang Y, Ren X, Gao J. Neuroendocrine carcinoma of the stomach: clinical features and CT findings. Abdom Radiol 2016;41:19-24. [DOI: 10.1007/s00261-015-0593-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
5 Volante M, Birocco N, Gatti G, Duregon E, Lorizzo K, Fazio N, Scagliotti GV, Papotti M. Extrapulmonary neuroendocrine small and large cell carcinomas: a review of controversial diagnostic and therapeutic issues. Human Pathology 2014;45:665-73. [DOI: 10.1016/j.humpath.2013.03.016] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
6 Lee HH, Jung CK, Jung ES, Song KY, Jeon HM, Park CH. Mixed exocrine and endocrine carcinoma in the stomach: a case report. J Gastric Cancer. 2011;11:122-125. [PMID: 22076213 DOI: 10.5230/jgc.2011.11.2.122] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
7 Ip YT, Pong WM, Kao SS, Chan JK. Spontaneous complete regression of gastric large-cell neuroendocrine carcinoma: mediated by cytomegalovirus-induced cross-autoimmunity? Int J Surg Pathol. 2011;19:355-358. [PMID: 21665860 DOI: 10.1177/1066896911404412] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
8 Fukuchi M, Sakurai S, Tsukagoshi R, Naitoh H, Kuwano H. A case of large cell neuroendocrine carcinoma of the esophagogastric junction. Esophagus 2015;12:295-9. [DOI: 10.1007/s10388-014-0443-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
9 Ren H, Shi SS, Wang NC, Wang X, Chen YT, Zhao DB. The Significant Influence of the Neuroendocrine Component on the Survival of Patients with Gastric Carcinoma Characterized by Coexisting Exocrine and Neuroendocrine Components. J Oncol 2019;2019:3671268. [PMID: 30992704 DOI: 10.1155/2019/3671268] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
10 Mjønes P, Sagatun L, Nordrum IS, Waldum HL. Neuron-Specific Enolase as an Immunohistochemical Marker Is Better Than Its Reputation. J Histochem Cytochem 2017;65:687-703. [PMID: 28972818 DOI: 10.1369/0022155417733676] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
11 Oberstein PE, Kenney B, Krishnamoorthy SK, Woo Y, Saif MW. Metastatic gastric large cell neuroendocrine carcinoma: a case report and review of literature. Clin Colorectal Cancer 2012;11:218-23. [PMID: 22421002 DOI: 10.1016/j.clcc.2012.01.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
12 Yuan G, Zhan C, Zhu D, Xie H, Wei T, Lu T, Yang Y, Zhu Y, Wang Q. Population-based analysis of esophageal large cell neuroendocrine carcinoma between 2004 and 2015. J Thorac Dis 2019;11:5480-8. [PMID: 32030267 DOI: 10.21037/jtd.2019.11.34] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Williams GT. Endocrine tumours of the gastrointestinal tract-selected topics. Histopathology. 2007;50:30-41. [PMID: 17204019 DOI: 10.1111/j.1365-2559.2006.02570.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
14 Rindi G, Inzani F, Solcia E. Pathology of Gastrointestinal Disorders. Endocrinology and Metabolism Clinics of North America 2010;39:713-27. [DOI: 10.1016/j.ecl.2010.08.009] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
15 Xie J, Zhao Y, Zhou Y, He Q, Hao H, Qiu X, Zhao G, Xu Y, Xue F, Chen J, Su G, Li P, Zheng CH, Huang CM. Predictive Value of Combined Preoperative Carcinoembryonic Antigen Level and Ki-67 Index in Patients With Gastric Neuroendocrine Carcinoma After Radical Surgery. Front Oncol. 2021;11:533039. [PMID: 33738246 DOI: 10.3389/fonc.2021.533039] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Solcia E, Klersy C, Mastracci L, Alberizzi P, Candusso ME, Diegoli M, Tava F, Riboni R, Manca R, Luinetti O. A combined histologic and molecular approach identifies three groups of gastric cancer with different prognosis. Virchows Arch. 2009;455:197-211. [PMID: 19672623 DOI: 10.1007/s00428-009-0813-z] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 1.9] [Reference Citation Analysis]
17 Volante M, Marci V, Andrejevic-Blant S, Tavaglione V, Sculli MC, Tampellini M, Papotti M. Increased neuroendocrine cells in resected metastases compared to primary colorectal adenocarcinomas. Virchows Arch 2010;457:521-7. [PMID: 20812018 DOI: 10.1007/s00428-010-0967-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
18 Nie L, Li M, He X, Feng A, Wu H, Fan X. Gastric mixed adenoneuroendocrine carcinoma: correlation of histologic characteristics with prognosis. Ann Diagn Pathol. 2016;25:48-53. [PMID: 27806846 DOI: 10.1016/j.anndiagpath.2016.09.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
19 Smith J, Reidy-lagunes D. The Management of Extrapulmonary Poorly Differentiated (High-Grade) Neuroendocrine Carcinomas. Seminars in Oncology 2013;40:100-8. [DOI: 10.1053/j.seminoncol.2012.11.011] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
20 Xie JW, Lu J, Lin JX, Zheng CH, Li P, Wang JB, Chen QY, Cao LL, Lin M, Tu RH, Huang CM. Different long-term oncologic outcomes after radical surgical resection for neuroendocrine carcinoma and adenocarcinoma of the stomach. Oncotarget 2017;8:57495-504. [PMID: 28915689 DOI: 10.18632/oncotarget.15488] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
21 Ishida M, Sekine S, Taniguchi H, Fukagawa T, Katai H, Kushima R. Consistent absence of HER2 expression, regardless of HER2 amplification status, in neuroendocrine carcinomas of the stomach. Histopathology 2014;64:1027-31. [DOI: 10.1111/his.12348] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
22 Sentani K, Oue N, Noguchi T, Sakamoto N, Matsusaki K, Yasui W. Immunostaining of gastric cancer with neuroendocrine differentiation: Reg IV-positive neuroendocrine cells are associated with gastrin, serotonin, pancreatic polypeptide and somatostatin. Pathol Int 2010;60:291-7. [PMID: 20403031 DOI: 10.1111/j.1440-1827.2010.02519.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
23 Waldum HL, Qvigstad G. Proton pump inhibitors and gastric neoplasia. Gut 2007;56:1019-20; author reply 1020. [PMID: 17566032 DOI: 10.1136/gut.2006.116434] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
24 Xie JW, Sun YQ, Feng CY, Zheng CH, Li P, Wang JB, Lin JX, Lu J, Chen QY, Cao LL. Evaluation of clinicopathological factors related to the prognosis of gastric neuroendocrine carcinoma. Eur J Surg Oncol. 2016;42:1464-1470. [PMID: 27570115 DOI: 10.1016/j.ejso.2016.08.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
25 Righi L, Volante M, Rapa I, Scagliotti GV, Papotti M. Neuro-endocrine tumours of the lung. A review of relevant pathological and molecular data. Virchows Arch 2007;451 Suppl 1:S51-9. [PMID: 17684766 DOI: 10.1007/s00428-007-0445-0] [Cited by in Crossref: 38] [Cited by in F6Publishing: 27] [Article Influence: 2.5] [Reference Citation Analysis]
26 Tsimpas A, Post NH, Moshel Y, Frempong-boadu AK. Large cell neuroendocrine carcinoma of the lung metastatic to the cauda equina. The Spine Journal 2010;10:e1-5. [DOI: 10.1016/j.spinee.2010.03.031] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
27 Kim BS, Park YS, Yook JH, Kim BS. Comparison of relapse-free survival in gastric neuroendocrine carcinoma (WHO grade 3) and gastric carcinoma. Therap Adv Gastroenterol. 2017;10:407-415. [PMID: 28507599 DOI: 10.1177/1756283x17697870] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
28 La Rosa S, Sessa F. High-grade poorly differentiated neuroendocrine carcinomas of the gastroenteropancreatic system: from morphology to proliferation and back. Endocr Pathol. 2014;25:193-198. [PMID: 24715269 DOI: 10.1007/s12022-014-9316-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
29 Chen J, Wang A, Ji K, Bu Z, Ji J. Comparison of overall survival of gastric neoplasms containing neuroendocrine carcinoma components with gastric adenocarcinoma: a propensity score matching study. BMC Cancer 2020;20:777. [PMID: 32811471 DOI: 10.1186/s12885-020-07281-7] [Reference Citation Analysis]
30 Terada T, Maruo H. Simultaneous large cell neuroendocrine carcinoma and adenocarcinoma of the stomach. World J Gastroenterol 2011; 17(43): 4831-4834 [PMID: 22147986 DOI: 10.3748/wjg.v17.i43.4831] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
31 Shibata Y, Ito Y, Fujita H, Okada Y, Nagai T, Sano H, Ito K. A novel case of functional gastric neuroendocrine carcinoma occurred after endoscopic submucosal dissection. Case Rep Gastrointest Med 2013;2013:148761. [PMID: 24307956 DOI: 10.1155/2013/148761] [Reference Citation Analysis]
32 Froio E, D'Adda T, Fellegara G, Martella E, Caruana P, Pruneri G, Pesci A, Rindi G. Uterine carcinosarcoma metastatic to the lung as large-cell neuroendocrine carcinoma with synchronous sarcoid granulomatosis. Lung Cancer 2009;64:371-7. [PMID: 19111933 DOI: 10.1016/j.lungcan.2008.11.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
33 Park JY, Ryu MH, Park YS, Park HJ, Ryoo BY, Kim MG, Yook JH, Kim BS, Kang YK. Prognostic significance of neuroendocrine components in gastric carcinomas. Eur J Cancer. 2014;50:2802-2809. [PMID: 25201164 DOI: 10.1016/j.ejca.2014.08.004] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 3.5] [Reference Citation Analysis]
34 Voutsadakis IA. Large cell neuroendocrine carcinoma of the ovary: A pathologic entity in search of clinical identity. World J Clin Oncol 2014; 5(2): 36-38 [PMID: 24829849 DOI: 10.5306/wjco.v5.i2.36] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
35 Sato K, Imai T, Shirota Y, Ueda Y, Katsuda S. Combined large cell neuroendocrine carcinoma and adenocarcinoma of the gallbladder. Pathol Res Pract. 2010;206:397-400. [PMID: 19945229 DOI: 10.1016/j.prp.2009.10.008] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
36 La Rosa S, Klersy C, Uccella S, Dainese L, Albarello L, Sonzogni A, Doglioni C, Capella C, Solcia E. Improved histologic and clinicopathologic criteria for prognostic evaluation of pancreatic endocrine tumors. Hum Pathol. 2009;40:30-40. [PMID: 18715612 DOI: 10.1016/j.humpath.2008.06.005] [Cited by in Crossref: 127] [Cited by in F6Publishing: 113] [Article Influence: 9.1] [Reference Citation Analysis]
37 Chiaravalli AM, Klersy C, Vanoli A, Ferretti A, Capella C, Solcia E. Histotype-based prognostic classification of gastric cancer. World J Gastroenterol 2012; 18(9): 896-904 [PMID: 22408348 DOI: 10.3748/wjg.v18.i9.896] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 32] [Article Influence: 2.9] [Reference Citation Analysis]
38 Kusafuka K, Ferlito A, Lewis JS Jr, Woolgar JA, Rinaldo A, Slootweg PJ, Gnepp DR, Devaney KO, Travis WD, Barnes L. Large cell neuroendocrine carcinoma of the head and neck. Oral Oncol 2012;48:211-5. [PMID: 22024350 DOI: 10.1016/j.oraloncology.2011.09.016] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 3.2] [Reference Citation Analysis]
39 Deng Y, Chen X, Ye Y, Shi X, Zhu K, Huang L, Zhang S, Ying M, Lin X. Histological characterisation and prognostic evaluation of 62 gastric neuroendocrine carcinomas. Contemp Oncol (Pozn) 2016;20:311-9. [PMID: 27688729 DOI: 10.5114/wo.2016.61852] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
40 Caruso RA, Fedele F, Consolo P, Luigiano C, Venuti A, Cavallari V. Abnormal Nuclear Structures (Micronuclei, Nucleoplasmic Bridges, and Nuclear Buds) in a Pleomorphic Giant Cell Carcinoma of the Stomach. Ultrastructural Pathology 2009;32:11-5. [DOI: 10.1080/01913120701829319] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
41 de Mestier L, Cros J. Digestive system mixed neuroendocrine-non-neuroendocrine neoplasms (MiNEN). Ann Endocrinol (Paris). 2019;80:172-173. [PMID: 31064662 DOI: 10.1016/j.ando.2019.04.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
42 Zhang P, Li Z, Li J, Li J, Zhang X, Lu Z, Sun Y, Li Y, Zhou J, Wang X, Peng Z, Shen L, Lu M. Clinicopathological features and lymph node and distant metastasis patterns in patients with gastroenteropancreatic mixed neuroendocrine-non-neuroendocrine neoplasm. Cancer Med 2021;10:4855-63. [PMID: 34109756 DOI: 10.1002/cam4.4031] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
43 La Rosa S, Inzani F, Vanoli A, Klersy C, Dainese L, Rindi G, Capella C, Bordi C, Solcia E. Histologic characterization and improved prognostic evaluation of 209 gastric neuroendocrine neoplasms. Hum Pathol. 2011;42:1373-1384. [PMID: 21531442 DOI: 10.1016/j.humpath.2011.01.018] [Cited by in Crossref: 119] [Cited by in F6Publishing: 101] [Article Influence: 10.8] [Reference Citation Analysis]
44 Jang KY, Moon WS, Lee H, Kim CY, Park HS. Gastric collision tumor of large cell neuroendocrine carcinoma and adenocarcinoma--a case report. Pathol Res Pract. 2010;206:387-390. [PMID: 19945227 DOI: 10.1016/j.prp.2009.09.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
45 Domori K, Nishikura K, Ajioka Y, Aoyagi Y. Mucin phenotype expression of gastric neuroendocrine neoplasms: analysis of histopathology and carcinogenesis. Gastric Cancer. 2014;17:263-272. [PMID: 23828549 DOI: 10.1007/s10120-013-0281-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
46 Song L, Jin Z, Zhang W, Zhang Y. Gastric large cell neuroendocrine carcinoma with venous tumor thrombus: the value of PET/CT and contrast-enhanced computed tomography. Clin Imaging 2015;39:325-8. [PMID: 25496669 DOI: 10.1016/j.clinimag.2014.09.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
47 Rustagi T, Rai M, Alekshun TJ. Gastric adenocarcinoma? Looks similar but behaves differently! J Gastrointest Cancer 2012;43:133-6. [PMID: 20957451 DOI: 10.1007/s12029-010-9220-6] [Reference Citation Analysis]
48 Speck O, Tang W, Morgan DR, Kuan PF, Meyers MO, Dominguez RL, Martinez E, Gulley ML. Three Molecular Subtypes of Gastric Adenocarcinoma Have Distinct Histochemical Features Reflecting Epstein-Barr Virus Infection Status and Neuroendocrine Differentiation. Appl Immunohistochem Mol Morphol 2015;23:633-45. [PMID: 25517873 DOI: 10.1097/PAI.0000000000000122] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
49 Ilett EE, Langer SW, Olsen IH, Federspiel B, Kjær A, Knigge U. Neuroendocrine Carcinomas of the Gastroenteropancreatic System: A Comprehensive Review. Diagnostics (Basel) 2015;5:119-76. [PMID: 26854147 DOI: 10.3390/diagnostics5020119] [Cited by in Crossref: 50] [Cited by in F6Publishing: 49] [Article Influence: 7.1] [Reference Citation Analysis]
50 Kusafuka K, Abe M, Iida Y, Onitsuka T, Fuke T, Asano R, Kamijo T, Nakajima T. Mucosal large cell neuroendocrine carcinoma of the head and neck regions in Japanese patients: a distinct clinicopathological entity. J Clin Pathol 2012;65:704-9. [PMID: 22718848 DOI: 10.1136/jclinpath-2012-200801] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
51 Chiaravalli AM, Klersy C, Tava F, Manca R, Fiocca R, Capella C, Solcia E. Lower- and higher-grade subtypes of diffuse gastric cancer. Hum Pathol. 2009;40:1591-1599. [PMID: 19540560 DOI: 10.1016/j.humpath.2009.04.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
52 Kadowaki Y, Nishimura T, Komoto S, Yuasa T, Tamura R, Okamoto T, Ishido N. Gastroduodenal intussusception caused by a gastric collision tumor consisting of adenocarcinoma and neuroendocrine carcinoma. Case Rep Gastroenterol. 2014;8:89-94. [PMID: 24803892 DOI: 10.1159/000356818] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
53 Dvorackova J, Macak J, Brzula P, Tomanova R, Dokulil J. Primary neuroendocrine carcinoma of the kidney. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2013;157:257-260. [PMID: 23073523 DOI: 10.5507/bp.2012.053] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
54 Mahansaria SS, Agrawal N, Arora A, Bihari C, Appukuttan M, Chattopadhyay TK. Ampullary Mixed Adenoneuroendocrine Carcinoma: Surprise Histology, Familiar Management. Int J Surg Pathol 2017;25:585-91. [PMID: 28552015 DOI: 10.1177/1066896917712454] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
55 Iso Y, Tagaya N, Nemoto T, Kita J, Sawada T, Kubota K. Incarceration of a large cell neuroendocrine carcinoma arising from the proximal stomach with an organoaxial gastric volvulus through an esophageal hiatal hernia: report of a case. Surg Today. 2009;39:148-152. [PMID: 19198995 DOI: 10.1007/s00595-008-3804-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
56 Takahashi K, Nihei T, Aoki Y, Konno N, Nakagawa M, Munakata A, Okawara K, Ohtani H, Kashimura H. Rapidly progressed large cell neuroendocrine carcinoma of the stomach with an increased serum alpha fetoprotein level: a case report. Clin J Gastroenterol 2020;13:225-32. [PMID: 31512156 DOI: 10.1007/s12328-019-01041-2] [Reference Citation Analysis]
57 Zou Y, Chen L, Wang X, Chen Y, Hu L, Zeng S, Wang P, Li G, Huang M, Wang L, He S, Li S, Jian L, Zhang S. Prognostic Threshold of Neuroendocrine Differentiation in Gastric Carcinoma: a Clinicopathological Study of 945 Cases. J Gastric Cancer 2019;19:121-31. [PMID: 30944765 DOI: 10.5230/jgc.2019.19.e9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
58 Mishima S, Kawazoe A, Matsumoto H, Kuboki Y, Bando H, Kojima T, Doi T, Ohtsu A, Yoshino T, Nonte EM, Chintharlapalli S, Nasir A, Kuwata T, Shitara K. Efficacy and safety of ramucirumab-containing chemotherapy in patients with pretreated metastatic gastric neuroendocrine carcinoma. ESMO Open 2018;3:e000443. [PMID: 30425849 DOI: 10.1136/esmoopen-2018-000443] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
59 Stojsic Z, Brasanac D, Bilanovic D, Mitrovic O, Stevanovic R, Boricic I. Large-cell neuroendocrine carcinoma of the ampulla of Vater. Med Oncol 2010;27:1144-8. [PMID: 19898974 DOI: 10.1007/s12032-009-9350-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
60 Jung HJ, Hong SJ, Han JP, Kim HS, Jeong GA, Cho GS, Kim HK, Ko BM, Lee MS. Long-term outcome of endoscopic and surgical resection for foregut neuroendocrine tumors. J Dig Dis. 2015;16:595-600. [PMID: 26315879 DOI: 10.1111/1751-2980.12279] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
61 Lin J, Zhao Y, Zhou Y, Tian Y, He Q, Lin J, Hao H, Zou B, Jiang L, Zhao G, Lin W, Xu Y, Li Z, Xue F, Li S, Fu W, Li Y, Xu Z, Li Y, Chen J, Zhou X, Zhu Z, Cai L, Li E, Li H, Zheng C, Li P, Huang C, Xie J. Comparison of Survival and Patterns of Recurrence in Gastric Neuroendocrine Carcinoma, Mixed Adenoneuroendocrine Carcinoma, and Adenocarcinoma. JAMA Netw Open 2021;4:e2114180. [PMID: 34313744 DOI: 10.1001/jamanetworkopen.2021.14180] [Reference Citation Analysis]
62 Payet E, Pilco PI, Montes J, Cordero-Morales A, Savitzky MJ, Stenning-Persivale K. Collision tumour of large-cell neuroendocrine carcinoma and adenocarcinoma in the stomach: A case report. Ecancermedicalscience 2016;10:616. [PMID: 26913067 DOI: 10.3332/ecancer.2016.616] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
63 Celikel C, Eren F, Gulluoglu B, Bekiroglu N, Turhal S. Relation of neuroendocrine cells to transforming growth factor-alpha and epidermal growth factor receptor expression in gastric adenocarcinomas: prognostic implications. Pathol Oncol Res 2007;13:215-26. [PMID: 17922051 DOI: 10.1007/BF02893502] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
64 Kim HJ, Choi BG, Kim CY, Cho CK, Kim JW, Lee JH, Hur YH. Collision tumor of the ampulla of Vater - Coexistence of neuroendocrine carcinoma and adenocarcinoma: report of a case. Korean J Hepatobiliary Pancreat Surg 2013;17:186-90. [PMID: 26155238 DOI: 10.14701/kjhbps.2013.17.4.186] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
65 Canzonieri V, Colarossi C, Del Col L, Perin T, Talamini R, Sigon R, Cannizzaro R, Aiello E, Buonadonna A, Italia F, Massi D, Carbone A, Memeo L. Exocrine and Endocrine Modulation in Common Gastric Carcinoma. Am J Clin Pathol 2012;137:712-21. [DOI: 10.1309/ajcpm13kvnczqbuv] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
66 Stojsic Z, Brasanac D, Stojiljkovic M, Babic D, Randjelovic T, Terzic T. Composite Carcinoma of the Stomach Associated with Sarcoid-Like Granulomas. Pathol Oncol Res 2009;15:503-10. [DOI: 10.1007/s12253-008-9145-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]